Search Results - David I. Bellovin
- Showing 1 - 2 results of 2
-
1
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer by Hong Xiang, Abigael G. Chan, Ago Ahene, David I. Bellovin, Rong Deng, Amy W. Hsu, Ursula Jeffry, Servando Palencia, Janine Powers, James Zanghi, Helen Collins
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC by Renumathy Dhanasekaran, Jangho Park, Alekesey Yevtodiyenko, David I. Bellovin, Stacey J. Adam, Anand Rajan KD, Meital Gabay, Hanan Fernando, Julia Arzeno, Vinodhini Arjunan, Sergei Gryanzov, Dean W. Felsher
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book